| Drug ID: | Drug131 |
|---|---|
| Drug Name: | Florilglutamic acid F-18 |
| CID: | 44473425 |
| DrugBank ID: | DB15041 |
| Modality: | Small Molecule |
| Groups: | NULL |
| US Approved: | NULL |
| Other Approved: | NULL |
| Identifier: | NCT03358706 |
| Molecular Formula: | C8H14FNO4 |
| Molecular Weight: | 206.2 g/mol |
| Isomeric SMILES: | C(C[C@@H](C[C@@H](C(=O)O)N)C(=O)O)C[18F] |
| Synonyms: | Florilglutamic acid (18F); Florilglutamic acid f-18; Florilglutamic acid (18-f); 18F-FSPG; Florilglutamic acid ((Sup 18)f); 1196963-74-2; UNII-92T1Y5X038; Florilglutamic acid (18F) [INN]; 92T1Y5X038; FSPG F-18 |
| Phase 0: | 0 |
| Phase 1: | 0 |
| Phase 2: | 0 |
| Phase 3: | 0 |
| Phase 4: | 0 |
| Description: | NULL |
Molecular Structure
Knowledge Graph
| dtID | CID | Compound Name | Gene ID | Gene Name | Species | PubMed IDs | Action |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
- No data available
Phase Distribution
Phase Description
- Phase 0: Exploratory trials to assess drug behavior in humans
- Phase 1: Safety trials to determine safe dosage range
- Phase 2: Efficacy trials to evaluate therapeutic effects
- Phase 3: Large-scale trials to confirm efficacy and safety
- Phase 4: Post-marketing surveillance for long-term safety and efficacy
| Trial ID | Title | Phase | Status | Sponsor | Indications | Interventions | |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
| Disease ID | Disease Name | Definition | Category | Related Drugs | Mechanism | |
|---|---|---|---|---|---|---|
| No data available | ||||||
| Strategy ID | Therapeutic Strategy | Synonyms | Related Drugs | Mechanism | |
|---|---|---|---|---|---|
| No data available | |||||
No related literature
You can run management commands to establish drug-literature associations